Chemistry:Dibutyl squarate

From HandWiki
Dibutyl squarate
Dibutyl squarate.svg
Names
IUPAC name
3,4-Dibutoxy-3-cyclobutene-1,2-dione
Other names
Squaric acid dibutyl ester; SADBE
Identifiers
3D model (JSmol)
1968189
ChEBI
ChEMBL
ChemSpider
DrugBank
EC Number
  • 628-906-7
UNII
Properties
C12H18O4
Molar mass 226.272 g·mol−1
Hazards
GHS pictograms GHS07: Harmful
GHS Signal word Warning
H315, H317, H319, H335
P261, P264, P264+265Script error: No such module "Preview warning".Category:GHS errors, P271, P272, P280, P302+352, P304+340, P305+351+338, P319Script error: No such module "Preview warning".Category:GHS errors, P321, P332+317Script error: No such module "Preview warning".Category:GHS errors, P333+313, P337+317Script error: No such module "Preview warning".Category:GHS errors, P362+364Script error: No such module "Preview warning".Category:GHS errors, P403+233, P405, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):

Dibutyl squarate (also known as squaric acid dibutyl ester or SADBE) is a chemical compound with the molecular formula C12H18O4. It is the dibutyl derivative of squaric acid.

Medically, it is used for the treatment of warts[1] and for treating alopecia areata or alopecia totalis (autoimmune hair loss) through topical immunotherapy involving the production of an allergic rash.[2][3] Dibutyl squarate is currently undergoing trials for use in treating herpes labialis (cold sores).[4]

References

  1. Silverberg, Nanette B.; Lim, Joseph K.; Paller, Amy S.; Mancini, Anthony J. (2000). "Squaric acid immunotherapy for warts in children". Journal of the American Academy of Dermatology 42 (5): 803–808. doi:10.1067/mjd.2000.103631. PMID 10775858. 
  2. Yoshimasu, Takashi; Furukawa, Fukumi (2016). "Modified immunotherapy for alopecia areata". Autoimmunity Reviews 15 (7): 664–667. doi:10.1016/j.autrev.2016.02.021. PMID 26932732. 
  3. Holzer, A. M.; Kaplan, L. L.; Levis, W. R. (2006). "Haptens as drugs: contact allergens are powerful topical immunomodulators". J. Drugs Dermatol. 5 (5): 410–416. PMID 16703776. 
  4. Kimball, Alexandra (2017-05-05). A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis. Massachusetts General Hospital. https://clinicaltrials.gov/ct2/show/NCT01971385.